| Primary |
| Hormone Replacement Therapy |
66.7% |
| Chronic Myeloid Leukaemia |
33.3% |
|
| Inappropriate Schedule Of Drug Administration |
14.3% |
| Mastectomy |
14.3% |
| Red Blood Cell Count Increased |
14.3% |
| Simple Mastectomy |
14.3% |
| Spinal Osteoarthritis |
14.3% |
| Thyroid Disorder |
14.3% |
| Urinary Tract Infection |
14.3% |
|
| Secondary |
| Hormone Replacement Therapy |
30.8% |
| Drug Use For Unknown Indication |
17.5% |
| Hormone Therapy |
8.8% |
| Product Used For Unknown Indication |
7.5% |
| Metrorrhagia |
6.7% |
| Myelodysplastic Syndrome |
5.0% |
| Menopause |
4.6% |
| Bone Marrow Failure |
3.3% |
| Osteoporosis |
3.3% |
| Foetal Exposure During Pregnancy |
2.5% |
| Vitamin Supplementation |
2.1% |
| In Vitro Fertilisation |
1.7% |
| Bipolar Disorder |
1.3% |
| Dry Eye |
1.3% |
| Breast Cancer |
0.8% |
| Glaucoma |
0.8% |
| Hypertension |
0.8% |
| Asthenia |
0.4% |
| Cerebrovascular Accident |
0.4% |
| Convulsion Prophylaxis |
0.4% |
|
| Breast Cancer |
27.3% |
| Completed Suicide |
9.1% |
| Peliosis Hepatis |
9.1% |
| Breast Cancer Female |
6.8% |
| Immune System Disorder |
6.8% |
| Hot Flush |
4.5% |
| Pubis Fracture |
4.5% |
| Weight Decreased |
4.5% |
| Abnormal Loss Of Weight |
2.3% |
| Arcus Lipoides |
2.3% |
| Drug Ineffective |
2.3% |
| Drug Interaction |
2.3% |
| International Normalised Ratio Abnormal |
2.3% |
| Invasive Ductal Breast Carcinoma |
2.3% |
| Irritable Bowel Syndrome |
2.3% |
| Malaise |
2.3% |
| Mood Altered |
2.3% |
| Nonspecific Reaction |
2.3% |
| Ocular Hyperaemia |
2.3% |
| Oesophageal Adenocarcinoma |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
20.6% |
| Rheumatoid Arthritis |
8.5% |
| Hormone Replacement Therapy |
6.0% |
| Depression |
4.5% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Hypertension |
3.7% |
| Pain |
3.6% |
| Blood Cholesterol Increased |
2.8% |
| Crohn's Disease |
2.6% |
| Anxiety |
2.2% |
| Asthma |
2.2% |
| Migraine |
2.1% |
| Vitamin Supplementation |
1.9% |
| Multiple Sclerosis |
1.9% |
| Fibromyalgia |
1.6% |
| Hypothyroidism |
1.6% |
| Osteoporosis |
1.4% |
| Hepatitis C |
1.3% |
| Arthralgia |
1.2% |
|
| Vomiting |
10.0% |
| Weight Increased |
10.0% |
| Wrong Technique In Drug Usage Process |
8.6% |
| Drug Ineffective |
6.2% |
| Urinary Tract Infection |
6.2% |
| Weight Decreased |
6.2% |
| Nausea |
4.8% |
| Pain In Extremity |
4.8% |
| Pruritus |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Flushing |
4.3% |
| Tremor |
4.3% |
| Rash |
3.8% |
| Vision Blurred |
3.8% |
| Off Label Use |
3.3% |
| Product Quality Issue |
3.3% |
| Headache |
2.9% |
| Injection Site Pain |
2.9% |
| Cholelithiasis |
2.4% |
| Pain |
2.4% |
|
| Interacting |
| Vitamin Supplementation |
50.0% |
| Autoimmune Thyroiditis |
25.0% |
| Product Used For Unknown Indication |
25.0% |
|
| Self Esteem Decreased |
100.0% |
|
